Navarro, C.; Ortega, Á.; Santeliz, R.; Garrido, B.; Chacín, M.; Galban, N.; Vera, I.; De Sanctis, J.B.; Bermúdez, V.
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics 2022, 14, 1303.
https://doi.org/10.3390/pharmaceutics14061303
AMA Style
Navarro C, Ortega Á, Santeliz R, Garrido B, Chacín M, Galban N, Vera I, De Sanctis JB, Bermúdez V.
Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics. 2022; 14(6):1303.
https://doi.org/10.3390/pharmaceutics14061303
Chicago/Turabian Style
Navarro, Carla, Ángel Ortega, Raquel Santeliz, Bermary Garrido, Maricarmen Chacín, Néstor Galban, Ivana Vera, Juan Bautista De Sanctis, and Valmore Bermúdez.
2022. "Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches" Pharmaceutics 14, no. 6: 1303.
https://doi.org/10.3390/pharmaceutics14061303
APA Style
Navarro, C., Ortega, Á., Santeliz, R., Garrido, B., Chacín, M., Galban, N., Vera, I., De Sanctis, J. B., & Bermúdez, V.
(2022). Metabolic Reprogramming in Cancer Cells: Emerging Molecular Mechanisms and Novel Therapeutic Approaches. Pharmaceutics, 14(6), 1303.
https://doi.org/10.3390/pharmaceutics14061303
